Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract.

Sturdevant GL, Kari L, Gardner DJ, Olivares-Zavaleta N, Randall LB, Whitmire WM, Carlson JH, Goheen MM, Selleck EM, Martens C, Caldwell HD.

Infect Immun. 2010 Sep;78(9):3660-8. doi: 10.1128/IAI.00386-10. Epub 2010 Jun 14.

PMID:
20547745
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.

Lyons JM, Morré SA, Airo-Brown LP, Peña AS, Ito JI.

J Microbiol Immunol Infect. 2005 Dec;38(6):383-93.

PMID:
16341338
[PubMed - indexed for MEDLINE]
3.

Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice.

Lyons JM, Morré SA, Airo-Brown LP, Peña AS, Ito JI.

BMC Infect Dis. 2005 Nov 17;5:105.

PMID:
16293190
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.

Darville T, Andrews CW Jr, Laffoon KK, Shymasani W, Kishen LR, Rank RG.

Infect Immun. 1997 Aug;65(8):3065-73.

PMID:
9234755
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Infectivity of urogenital Chlamydia trachomatis plasmid-deficient, CT135-null, and double-deficient strains in female mice.

Sturdevant GL, Zhou B, Carlson JH, Whitmire WM, Song L, Caldwell HD.

Pathog Dis. 2014 Jun;71(1):90-2. doi: 10.1111/2049-632X.12121. Epub 2014 Jan 13.

PMID:
24376189
[PubMed - in process]
7.

The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.

Whittum-Hudson JA, Rudy D, Gèrard H, Vora G, Davis E, Haller PK, Prattis SM, Hudson AP, Saltzman WM, Stuart ES.

Vaccine. 2001 Jul 16;19(28-29):4061-71.

PMID:
11427283
[PubMed - indexed for MEDLINE]
8.

Plasmid CDS5 influences infectivity and virulence in a mouse model of Chlamydia trachomatis urogenital infection.

Ramsey KH, Schripsema JH, Smith BJ, Wang Y, Jham BC, O'Hagan KP, Thomson NR, Murthy AK, Skilton RJ, Chu P, Clarke IN.

Infect Immun. 2014 Aug;82(8):3341-9. doi: 10.1128/IAI.01795-14. Epub 2014 May 27.

PMID:
24866804
[PubMed - indexed for MEDLINE]
9.

Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse model.

Sigar IM, Schripsema JH, Wang Y, Clarke IN, Cutcliffe LT, Seth-Smith HM, Thomson NR, Bjartling C, Unemo M, Persson K, Ramsey KH.

Pathog Dis. 2014 Feb;70(1):61-9. doi: 10.1111/2049-632X.12086. Epub 2013 Sep 10.

PMID:
24022847
[PubMed - indexed for MEDLINE]
10.

The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor.

Carlson JH, Whitmire WM, Crane DD, Wicke L, Virtaneva K, Sturdevant DE, Kupko JJ 3rd, Porcella SF, Martinez-Orengo N, Heinzen RA, Kari L, Caldwell HD.

Infect Immun. 2008 Jun;76(6):2273-83. doi: 10.1128/IAI.00102-08. Epub 2008 Mar 17.

PMID:
18347045
[PubMed - indexed for MEDLINE]
Free PMC Article
11.
12.

Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model.

Carmichael JR, Tifrea D, Pal S, de la Maza LM.

Microbes Infect. 2013 Mar;15(3):219-29. doi: 10.1016/j.micinf.2012.12.001. Epub 2012 Dec 31.

PMID:
23287699
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.

Ito JI Jr, Lyons JM, Airo-Brown LP.

Infect Immun. 1990 Jun;58(6):2021-3.

PMID:
2341189
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

An integrated approach to the study of Chlamydia trachomatis infection of the female genital tract.

Lyons JM.

Drugs Today (Barc). 2006 Mar;42 Suppl A:83-97. Review.

PMID:
16683048
[PubMed - indexed for MEDLINE]
15.
16.

Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations.

Suchland RJ, Jeffrey BM, Xia M, Bhatia A, Chu HG, Rockey DD, Stamm WE.

Infect Immun. 2008 Dec;76(12):5438-46. doi: 10.1128/IAI.00984-08. Epub 2008 Oct 13.

PMID:
18852248
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A model of genital Chlamydia trachomatis infection using human xenografts in severe combined immunodeficiency mice.

Essig A, Rudolphi A, Heinemann M, Rosenthal H, Kaufmann R, Reimann J, Marre R.

Infect Immun. 1996 Jun;64(6):2300-7.

PMID:
8675341
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs?

Darville T, Andrews CW Jr, Rank RG.

Infect Immun. 2000 Sep;68(9):5299-305.

PMID:
10948158
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Identification of candidate genes using the murine model of female genital tract infection with Chlamydia trachomatis.

Lyons JM, Igietseme JU, Black CM, Morré SA.

Drugs Today (Barc). 2009 Nov;45 Suppl B:51-9. Review.

PMID:
20011695
[PubMed - indexed for MEDLINE]
20.

Experimental infection of the marmoset genital tract with Chlamydia trachomatis.

Johnson AP, Hetherington CM, Osborn MF, Thomas BJ, Taylor-Robinson D.

Br J Exp Pathol. 1980 Jun;61(3):291-5.

PMID:
7426384
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk